Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Vessel maturation schedule determines vulnerability to neuronal injuries of prematurity
Tamar Licht, … , Gadiel Rothe, Eli Keshet
Tamar Licht, … , Gadiel Rothe, Eli Keshet
Published February 17, 2015
Citation Information: J Clin Invest. 2015;125(3):1319-1328. https://doi.org/10.1172/JCI79401.
View: Text | PDF
Research Article

Vessel maturation schedule determines vulnerability to neuronal injuries of prematurity

  • Text
  • PDF
Abstract

Premature birth is a major risk factor for multiple brain pathologies, notably periventricular leukomalacia (PVL), which is distinguished by bilateral necrosis of neural tissue around the ventricles and a sequela of neurological disturbances. The 2 hallmarks of brain pathologies of prematurity are a restricted gestational window of vulnerability and confinement of injury to a specific cerebral region. Here, we examined the proposition that both of these features are determined by the state of blood vessel immaturity. We developed a murine genetic model that allows for inducible and reversible VEGF blockade during brain development. Using this system, we determined that cerebral vessels mature in a centrifugal, wave-like fashion that results in sequential acquisition of a functional blood-brain barrier and exit from a VEGF-dependent phase, with periventricular vessels being the last to mature. This developmental program permitted selective ablation of periventricular vessels via episodic VEGF blockade within a specific, vulnerable gestational window. Enforced collapse of ganglionic eminence vessels and resultant periventricular neural apoptosis resulted in a PVL-like phenotype that recapitulates the primary periventricular lesion, ventricular enlargement, and the secondary cortical deficit in out-migrating GABAergic inhibitory interneurons. These findings provide an animal model that reproduces the temporal and spatial specificities of PVL and indicate that damage to VEGF-dependent, immature periventricular vessels contributes to PVL development.

Authors

Tamar Licht, Talia Dor-Wollman, Ayal Ben-Zvi, Gadiel Rothe, Eli Keshet

×

Figure 3

Cerebral apoptosis induced by global VEGF LOF with the aid of a rosa26-rtTa driver line.

Options: View larger image (or click on image) Download as PowerPoint
Cerebral apoptosis induced by global VEGF LOF with the aid of a rosa26-r...
(A) Schematic of transgenic mouse lines used. (B) Immunostaining for hVEGFR1 in E15.5 brain induced 1 day earlier (noninduced littermate control on left). Note robust induction of the VEGF-trapping receptor throughout. Scale bar: 200 μm. (C) E14.5 brains in which sVEGFR1 was switched on 1 day earlier stained for blood vessels (IB4) and apoptosis (cleaved caspase-3) and highlighting GE-specific apoptosis, including EC apoptosis. Higher magnification is shown on right. Scale bars: 100 μm (left, middle); 20 μm (right). (D) E15.5 brain switched on 1 day earlier and showing no evidence for GE apoptosis. Scale bar: 100 μm. Image observations were reproduced 3 times.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts